Projects per year
Fingerprint Dive into the research topics where Helen Rizos is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 8 Similar Profiles
Melanoma
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Tumor Suppressor Protein p14ARF
Medicine & Life Sciences
Mitogen-Activated Protein Kinase Kinases
Medicine & Life Sciences
Mutation
Medicine & Life Sciences
Tumors
Chemical Compounds
Melanocytes
Medicine & Life Sciences
Mitogen-Activated Protein Kinases
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2014 2022
Understanding the immune contexture and signalling crosstalk between tumour and immune cells in glioblastoma
Vaqueirinho de Pinho, A., Shklovskaya, E., Rizos, H. & De Souza, P.
1/01/19 → 31/12/20
Project: Research
Centre of Research Excellence in Melanoma: Person, tumour and system-focussed knowledge to drive better outcomes in melanoma
Braithwaite, J., Mann, G. J., Cust, A. E., Scolyer, R. A., Kelly, J., Morton, R. L., Spillane, A. J., Saw, R., Henderson, M., Yang, J. Y. H., Hong, A., Tran, A., Gyorki, D., Milne, D., Long, G. V., Rizos, H., Kasparian, N., Fernández-Peñas, P. & Guitera, P.
1/01/18 → 31/12/22
Project: Other
Differential effects of MAPK inhibition on immune activity determine melanoma response
Lim, S. Y., Rizos, H. & Kefford, R.
17/04/17 → …
Project: Research
Blood based biomarkers of prognosis, treatment response and treatment resistance (liquid biopsies)
17/01/17 → …
Project: Research
Determinants of response to immune checkpoint inhibitors in melanoma
Rizos, H., Long, G., Menzies, A. M., Yang, J., Carlino, M., Kefford, R., Scolyer, R., MQRES, M., MQRES 3 (International), M. 3. & De St Groth, B. F.
1/01/17 → …
Project: Research
Research Outputs 1989 2019
Analysis of the whole-exome sequencing of tumor and circulating tumor DNA in metastatic melanoma
Diefenbach, R. J., Lee, J. H., Strbenac, D., Yang, J. Y. H., Menzies, A. M., Carlino, M. S., Long, G. V., Spillane, A. J., Stretch, J. R., Saw, R. P. M., Thompson, J. F., Ch'ng, S., Scolyer, R. A., Kefford, R. F. & Rizos, H., 29 Nov 2019, In : Cancers. 11, 12, p. 1-14 14 p., 1905.Research output: Contribution to journal › Article › Research › peer-review
Open Access
File
Exome
Melanoma
DNA
Neoplasms
Mutation
Circulating cytokines predict immune-related toxicity in melanoma patients receiving anti-PD-1 based immunotherapy
Lim, S. Y., Lee, J. H., Nur Gide, T., Menzies, A. M., Guminski, A., Carlino, M. S., Breen, E., Yang, J. Y. H., Ghazanfar, S., Kefford, R. F., Scolyer, R. A., Long, G. V. & Rizos, H., Mar 2019, In : Clinical Cancer Research. 25, 5, p. 1557-1563 7 p.Research output: Contribution to journal › Article › Research › peer-review
Immunotherapy
Melanoma
Cytokines
Confidence Intervals
Therapeutics
Distinct immune cell populations define response to anti-PD-1 monotherapy and anti-PD-1/anti-CTLA-4 combined therapy
Gide, T. N., Quek, C., Menzies, A. M., Tasker, A. T., Shang, P., Holst, J., Madore, J., Lim, S. Y., Velickovic, R., Wongchenko, M., Yan, Y., Lo, S., Carlino, M. S., Guminski, A., Saw, R. P. M., Pang, A., McGuire, H. M., Palendira, U., Thompson, J. F., Rizos, H. & 5 others, 11 Feb 2019, In : Cancer Cell. 35, 2, p. 238-255.e6 24 p.Research output: Contribution to journal › Article › Research › peer-review
T-Lymphocytes
Immunotherapy
Population
Neoplasms
Therapeutics
Distinct molecular profiles and immunotherapy treatment outcomes of V600E and V600K BRAF-mutant melanoma
da Silva, I. P., Wang, K. Y. X., Wilmott, J. S., Holst, J., Carlino, M. S., Park, J. J., Quek, C., Wongchenko, M., Yan, Y., Mann, G., Johnson, D. B., McQuade, J. L., Rai, R., Kefford, R. F., Rizos, H., Scolyer, R. A., Yang, J. Y. H., Long, G. V. & Menzies, A. M., 15 Feb 2019, In : Clinical Cancer Research. 25, 4, p. 1272-1279 8 p.Research output: Contribution to journal › Article › Research › peer-review
Immunotherapy
Melanoma
MAP Kinase Signaling System
Atlases
Dual Specificity Phosphatase 6
Emerging novel therapies in overcoming resistance to targeted therapy
Pinho, A. V., Lee, J. H. & Rizos, H., 2019, Current applications for overcoming resistance to targeted therapies. Szewczuk, M. R., Qorri, B. & Sambi, M. (eds.). Switzerland: Springer, Springer Nature, p. 223-258 36 p. (Resistance to Targeted Anti-Cancer Therapeutics; vol. 20).Research output: Chapter in Book/Report/Conference proceeding › Chapter › Research › peer-review
Melanoma
Neoplasms
Therapeutics
Physiologic Monitoring
Leukemia, Myelogenous, Chronic, BCR-ABL Positive